Skip to main content

Find Clinical Trials

Home
Conditions
Live Attenuated Influenza Vaccine

Clinical trial condition

Live Attenuated Influenza Vaccine

Explore clinical trials studying Live Attenuated Influenza Vaccine. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Live Attenuated Influenza Vaccine trial results

Completed

A Phase III/IV Open-label Study of the Immunogenicity and Safety of a Single Dose of a Live Attenuated Influenza Vaccine (LAIV) (FluenzTM) for Each of Three Successive Years in Children naïve to, or in Previous Receipt of the AS03B Adjuvanted H1N1 (2009) Influenza Vaccine (Pandemrix ™).

NCT02143882

Conditions: Live Attenuated Influenza Vaccine
Locations: Gloucestershire Gloucestershire, United Kingdom

Hertfordshire Hertfordshire, United Kingdom

View Trial Details